LD-2 disclosure · 4th Quarter - Report
APOTEX CORP.
via APOTEX CORP.
Expenses$520Kself-filed spend
Client
- Name
- APOTEX CORP.
- Location
- Florida · United States of America
Registrant
- Firm
- APOTEX CORP.
- Description
- Generic pharmaceutical manufacturer
- Location
- WESTON, Florida, United States of America
Lobbying activities
1 issueHealth Issues
H.R. 2853, the BLOCKING Act, provisions relating to amending the Hatch-Waxman Act's 180-day exclusivity structure; and S. 4348, the Food and Drug Safety and Landmark Advancements Act, Section 515, 180 Day Exclusivity Period, provisions relating to amending the Hatch-Waxman Act's 180-day exclusivity structure to prevent market blockages.
LobbyistsSTEVEN GIULI
TargetedSENATE · HOUSE OF REPRESENTATIVES